Dr. Steven Victor Becker , MD
General Practice • Houston, TX
909 Dairy Ashford Rd 112
Houston, TX 770795306
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Steven Becker is listed in NPPES under General Practice.
-
NPI assigned on August 2, 2006; this date does not establish years in practice.
-
Published CMS data list 596 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- G2212 — Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or: 339 service units.
- 99215 — Established patient outpatient office visit: 234 service units.
- G2211 — Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's: 23 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See the full table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,980 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Rosuvastatin Calcium — 159 prescription fills, including refills.
- Atorvastatin Calcium — 123 prescription fills, including refills.
- Levothyroxine Sodium — 110 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 64 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 70% of clinicians listed under General Practice in Houston, TX (2024, 28 clinicians with data). Median for this group: 223. Middle half: 73 to 747.
More Medicare Part B services than 60% of clinicians listed under General Practice in Texas (2024, 172 clinicians with data). Median for this group: 341. Middle half: 100 to 1,551.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 311 in 2020 to 596 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
909 Dairy Ashford Rd 112
Houston, TX 770795306
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
1974
What Public CMS Data Show
General Practice: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
65 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $49,358 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $37,538 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
3,987 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$390,771 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $642.13 across 23 records.
By nature of payment
- Food and Beverage: $626.21 across 21 records.
- Education: $15.92 across 2 records.
Reporting-company totals (3 largest of 8)
- Amgen Inc.: $431.58 across 13 records.
- Eli Lilly and Company: $57.13 across 3 records.
- AstraZeneca Pharmaceuticals LP: $34.75 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
52 years (graduated 1974)
CMS Doctors and Clinicians data list 1974 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Becker has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Becker as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Houston and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 70% of clinicians listed under General Practice in Houston, TX (2024, 28 clinicians with data). Median for this group: 223. Middle half: 73 to 747.
More Medicare Part B services than 60% of clinicians listed under General Practice in Texas (2024, 172 clinicians with data). Median for this group: 341. Middle half: 100 to 1,551.
Medicare-allowed amount
A higher Medicare-allowed amount than 65% of clinicians listed under General Practice in Houston, TX (2024, 28 clinicians with data). Median for this group: $20,660. Middle half: $9,422 to $74,378.
A higher Medicare-allowed amount than 60% of clinicians listed under General Practice in Texas (2024, 172 clinicians with data). Median for this group: $28,596. Middle half: $8,918 to $83,485.
Paid by Medicare
A higher Medicare payment amount than 65% of clinicians listed under General Practice in Houston, TX (2024, 28 clinicians with data). Median for this group: $14,270. Middle half: $6,534 to $56,228.
A higher Medicare payment amount than 60% of clinicians listed under General Practice in Texas (2024, 172 clinicians with data). Median for this group: $19,146. Middle half: $6,451 to $65,134.
Medicare Part D prescriptions
More Part D prescriptions than 65% of clinicians listed under General Practice in Houston, TX (2024, 36 clinicians with data). Median for this group: 577. Middle half: 85 to 2,785.
More Part D prescriptions than 70% of clinicians listed under General Practice in Texas (2024, 221 clinicians with data). Median for this group: 452. Middle half: 78 to 2,858.
Part D drug cost
A higher Part D drug cost than 70% of clinicians listed under General Practice in Houston, TX (2024, 36 clinicians with data). Median for this group: $20,647. Middle half: $2,458 to $392,192.
A higher Part D drug cost than 80% of clinicians listed under General Practice in Texas (2024, 221 clinicians with data). Median for this group: $17,804. Middle half: $993 to $222,529.
133 active clinicians are listed under General Practice with a practice address in Houston, TX (1,066 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Houston
6.8% of these 133 clinicians have the CMS telehealth indicator.
30.1% of these 133 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 92% from 311 in 2020 to 596 in 2024.
- 2020: 311
- 2021: 198
- 2022: 458
- 2023: 482
- 2024: 596
-
Medicare-allowed amount
Medicare-allowed amount increased 55% from $31,923 in 2020 to $49,358 in 2024.
- 2020: $31,923
- 2021: $18,254
- 2022: $40,188
- 2023: $44,516
- 2024: $49,358
-
Paid by Medicare
Paid by Medicare increased 54% from $24,454 in 2020 to $37,538 in 2024.
- 2020: $24,454
- 2021: $14,001
- 2022: $31,635
- 2023: $34,533
- 2024: $37,538
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 18% from 2,424 in 2020 to 1,980 in 2024.
- 2020: 2,424
- 2021: 2,187
- 2022: 2,259
- 2023: 2,303
- 2024: 1,980
-
30-day fills
30-day fills stayed about the same: 4,062 in 2020 and 3,987 in 2024.
- 2020: 4,062
- 2021: 3,819
- 2022: 3,903
- 2023: 4,023
- 2024: 3,987
-
Part D drug cost
Part D drug cost increased 51% from $259,243 in 2020 to $390,771 in 2024.
- 2020: $259,243
- 2021: $284,446
- 2022: $318,918
- 2023: $381,621
- 2024: $390,771
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $253.21 in 2021 to $642.13 in 2025.
- 2021: $253.21
- 2022: $446.72
- 2023: $244.18
- 2024: $501.56
- 2025: $642.13
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 23 records totaling $642.13.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
REPATHA | General | $151.79 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
OTEZLA | General | $118.99 |
| VERTEX PHARMACEUTICALS INCORPORATED |
Food and Beverage
In-kind items and services
|
JOURNAVX | General | $28.76 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $27.96 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
REPATHA | General | $26.05 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
EVENITY | General | $25.77 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
EVENITY | General | $24.30 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
TREMFYA | General | $23.15 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
PAXLOVID | General | $22.47 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
Repatha | General | $21.90 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $19.17 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
— | General | $19.04 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $18.92 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $18.26 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
EVENITY | General | $17.90 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $16.49 |
| Medtronic, Inc. |
Food and Beverage
In-kind items and services
|
INCEPTIV | General | $16.33 |
| Amgen Inc. |
Education
In-kind items and services
|
REPATHA | General | $7.96 |
| Amgen Inc. |
Education
In-kind items and services
|
REPATHA | General | $7.96 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
OTEZLA | General | $7.82 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
REPATHA | General | $7.18 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
OTEZLA | General | $7.02 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
REPATHA | General | $6.94 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
G2212
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or
|
339 | 63 | $40.00 | $32.18 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
234 | 61 | $199.15 | $162.70 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
23 | 17 | $29.57 | $16.41 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 159 | 12,406 | $2,461.14 | 39 |
| Atorvastatin Calcium | Atorvastatin Calcium | 123 | 8,793 | $1,787.27 | 31 |
| Levothyroxine Sodium | Levothyroxine Sodium | 110 | 7,195 | $1,371.14 | 28 |
| Synthroid | Levothyroxine Sodium | 58 | 4,176 | $4,431.45 | 13 |
| Amlodipine Besylate | Amlodipine Besylate | 55 | 4,306 | $590.21 | 16 |
| Metoprolol Succinate | Metoprolol Succinate | 51 | 4,253 | $1,634.28 | 15 |
| Azithromycin | Azithromycin | 50 | 772 | $375.96 | 35 |
| Jardiance | Empagliflozin | 50 | 3,960 | $72,884.43 | 14 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 48 | 3,120 | $4,142.55 | 13 |
| Farxiga | Dapagliflozin Propanediol | 47 | 2,310 | $42,956.48 | 14 |
| Gabapentin | Gabapentin | 45 | 1,968 | $981.06 | 12 |
| Losartan Potassium | Losartan Potassium | 44 | 2,955 | $483.93 | — |
| Repatha Sureclick | Evolocumab | 44 | 2,470 | $45,643.17 | 11 |
| Montelukast Sodium | Montelukast Sodium | 41 | 3,150 | $713.64 | 14 |
| Famotidine | Famotidine | 41 | 2,476 | $989.81 | 15 |
| Tamsulosin Hcl | Tamsulosin Hcl | 40 | 2,955 | $1,337.35 | — |
| Telmisartan | Telmisartan | 37 | 2,850 | $1,321.71 | 11 |
| Mounjaro | Tirzepatide | 37 | 1,092 | $39,381.18 | — |
| Azelastine Hcl | Azelastine Hcl | 35 | 2,344 | $1,197.85 | 13 |
| Eliquis | Apixaban | 35 | 1,830 | $34,096.91 | — |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 32 | 2,010 | $2,613.99 | — |
| Tramadol Hcl | Tramadol Hcl | 30 | 664 | $505.71 | 11 |
| Celecoxib | Celecoxib | 30 | 1,640 | $922.25 | — |
| Vascepa | Icosapent Ethyl | 28 | 1,947 | $22,750.36 | — |
| Ezetimibe | Ezetimibe | 28 | 2,040 | $512.53 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2020-02-04NUCC Taxonomy Code: 208D00000X
A physician who specializes in the general practice of diagnosing, treating, and managing patients with a variety of illnesses and conditions.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - GENERAL PRACTICE
I20041130000716
TX
8123083243
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
General Practice (license number reported to NPPES: TX E9107)
NPI status registered as active in NPPES database
Registered at 909 DAIRY ASHFORD RD 112, HOUSTON, TX 770795306 (Tel: 7139321924)
Registered at 1918 SADDLECREEK DR, HOUSTON, TX 770902039 (Tel: 7139321924)
Recorded as STEVEN BECKER, MD
Family Medicine (license number reported to NPPES: TX E9107)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other General Practices in Houston
- Dr. Manuel Garcia Galdo, MD
- Dr. Stephen Patin, MD, MPH
- Dr. Jesus Mayor, MD
- Dr. Courtney Mcneely, MD
- Dr. Azim Karim, MD
- Dr. Zsolt Garami, MD
Mailing Address
1918 Saddlecreek Dr
Houston, TX 770902039
Phone: 7139321924